BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6098419)

  • 1. Converting enzyme activity in regulation of blood pressure and kidney function. A review.
    Piryova B; Girchev R
    Cor Vasa; 1984; 26(6):401-7. PubMed ID: 6098419
    [No Abstract]   [Full Text] [Related]  

  • 2. The renin-angiotensin system and body function.
    Reid IA
    Arch Intern Med; 1985 Aug; 145(8):1475-9. PubMed ID: 2992406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
    Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of the angiotensin-converting enzyme--effect on kidney function and electrolyte balance].
    Kramer HJ
    Z Kardiol; 1988; 77 Suppl 3():39-45. PubMed ID: 3062959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converting enzyme inhibition in mild and moderate essential hypertension. II.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1986; 219(1):29-36. PubMed ID: 3006449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of blood plasma carboxycathepsin (angiotensin I-converting enzyme) in normo- and hypertensive rats in response to a single administration of captopril].
    Kugaevskaia EV; Eliseeva IuE; Pavlikhina LV; Orekhovich VN; Faermark IF
    Biull Eksp Biol Med; 1987 Jan; 103(1):48-50. PubMed ID: 3026518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
    Cottone S; Grasso L; D'Ignoto G; Contorno A; Ziletti T; Carapelle E; Carone MB; Fulantelli MA; Cerasola G
    Boll Soc Ital Biol Sper; 1987 Sep; 63(9):803-10. PubMed ID: 2833914
    [No Abstract]   [Full Text] [Related]  

  • 9. Tonin--angiotensin II system in hypertension.
    Boucher R; Garcia R; Gutkowska J; Demassieux S; Genest J
    Clin Sci Mol Med Suppl; 1978 Dec; 4():183s-186s. PubMed ID: 215373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral effects of ACE-inhibition.
    Cerasola G; Cottone S; Grasso L; D'Ignoto G; Carone MB; Carapelle E; Fulantelli MA; Contorno A
    Boll Soc Ital Biol Sper; 1987 Mar; 63(3):195-200. PubMed ID: 2820442
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypotensive responses of different types of Goldblatt hypertensive rat to MK-421].
    Wang H; Gu TH; Pan WH
    Yao Xue Xue Bao; 1986 Jun; 21(6):469-71. PubMed ID: 3028039
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy.
    Niarchos AP; Resnick LM; Weinstein DL; Laragh JH
    Am J Med; 1985 Oct; 79(4):435-44. PubMed ID: 2864856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin-converting-enzyme inhibition in arterial hypertension].
    Waeber B; Nussberger J; Brunner HR
    Wien Med Wochenschr; 1990 Jan; 140(1-2):22-30. PubMed ID: 2408247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Captopril--an inhibitor of the angiotensin I converting enzyme--in the treatment of arterial hypertension in chronic kidney failure patients].
    Manasia M; Paţiu IM; Vlăduţiu D; Madi A; Barabas E; Gherman M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(3):217-22. PubMed ID: 2865784
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of captopril and hydrochlorothiazide on glomerular haemodynamics and histological damage in Goldblatt hypertension with partial renal ablation.
    Herrera-Acosta J; Gabbai FB; Tapia E; Cermeño JL; Calleja C; Bobadilla NA; Romero L
    J Hypertens Suppl; 1986 Dec; 4(5):S275-8. PubMed ID: 3553476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of renin-angiotensin system in chronic renal hypertensive rats.
    Sen S; Smeby RR; Bumpus FM; Turcotte JG
    Hypertension; 1979; 1(4):427-34. PubMed ID: 232087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition.
    Brunner HR; Waeber B; Nussberger J
    Kidney Int Suppl; 1988 Oct; 26():S80-5. PubMed ID: 2904507
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the angiotensin converting enzyme inhibitor, captopril (SQ14,225), on orthostatic sodium and water retention in patients with idiopathic edema.
    Suzuki H; Fujimaki M; Nakane H; Saito I; Takeshita E; Saruta T
    Nephron; 1985; 39(3):244-9. PubMed ID: 2983253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.